Biomarker-Directed Therapies for Advanced Prostate Cancer

Biomarker-Directed Therapies for Advanced Prostate Cancer

Dive into this Clinical Case Challenge and test your expertise in managing advanced prostate cancer. With interactive multiple-choice questions and evidence-based rationales, you’ll gain actionable insights into biomarker testing, precision-targeted therapies, and managing treatment-related adverse events. Don’t miss this opportunity to sharpen your skills and deliver guideline-concordant care for patients with advanced prostate cancer.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/driving-guideline-concordant-biomarker-driven-care-advanced-prostate-cancer
  • Start Date: 2025-02-28 06:00:00
  • End Date: 2025-02-28 06:00:00
  • Credit Details: IPCE Credits: 0.25 hours
    AAPA Category 1 Credit™️: 0.25 hours
    AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.25 hours
    Pharmacy: 0.25 hours
  • Commercial Support: Source: Pfizer (Any division) - Amount: 24875.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.